Global Medical REIT Statistics
Total Valuation
GMRE has a market cap or net worth of $474.62 million. The enterprise value is $1.18 billion.
Important Dates
The last earnings date was Tuesday, November 4, 2025, after market close.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | Dec 19, 2025 |
Share Statistics
GMRE has 13.85 million shares outstanding. The number of shares has increased by 1.95% in one year.
| Current Share Class | 13.41M |
| Shares Outstanding | 13.85M |
| Shares Change (YoY) | +1.95% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 0.55% |
| Owned by Institutions (%) | 69.23% |
| Float | 12.59M |
Valuation Ratios
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | 156.32 |
| PS Ratio | 3.25 |
| Forward PS | 3.10 |
| PB Ratio | 1.15 |
| P/TBV Ratio | 1.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 6.57 |
| PEG Ratio | 22.84 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.18 |
| EV / EBITDA | 13.53 |
| EV / EBIT | 34.69 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.91, with a Debt / Equity ratio of 1.43.
| Current Ratio | 1.91 |
| Quick Ratio | 1.71 |
| Debt / Equity | 1.43 |
| Debt / EBITDA | 7.84 |
| Debt / FCF | n/a |
| Interest Coverage | 1.10 |
Financial Efficiency
Return on equity (ROE) is 0.41% and return on invested capital (ROIC) is 1.76%.
| Return on Equity (ROE) | 0.41% |
| Return on Assets (ROA) | 1.70% |
| Return on Invested Capital (ROIC) | 1.76% |
| Return on Capital Employed (ROCE) | 2.75% |
| Revenue Per Employee | $5.57M |
| Profits Per Employee | -$127,846 |
| Employee Count | 26 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.83% in the last 52 weeks. The beta is 1.20, so GMRE's price volatility has been higher than the market average.
| Beta (5Y) | 1.20 |
| 52-Week Price Change | -16.83% |
| 50-Day Moving Average | 32.49 |
| 200-Day Moving Average | 35.18 |
| Relative Strength Index (RSI) | 63.62 |
| Average Volume (20 Days) | 151,852 |
Short Selling Information
The latest short interest is 752,662, so 5.43% of the outstanding shares have been sold short.
| Short Interest | 752,662 |
| Short Previous Month | 730,016 |
| Short % of Shares Out | 5.43% |
| Short % of Float | 5.98% |
| Short Ratio (days to cover) | 4.43 |
Income Statement
In the last 12 months, GMRE had revenue of $144.83 million and -$3.32 million in losses. Loss per share was -$0.25.
| Revenue | 144.83M |
| Gross Profit | 144.67M |
| Operating Income | 34.15M |
| Pretax Income | 2.20M |
| Net Income | -3.32M |
| EBITDA | 87.53M |
| EBIT | 34.15M |
| Loss Per Share | -$0.25 |
Full Income StatementBalance Sheet
The company has $14.59 million in cash and $723.14 million in debt, giving a net cash position of -$708.55 million or -$51.15 per share.
| Cash & Cash Equivalents | 14.59M |
| Total Debt | 723.14M |
| Net Cash | -708.55M |
| Net Cash Per Share | -$51.15 |
| Equity (Book Value) | 505.83M |
| Book Value Per Share | 30.61 |
| Working Capital | 27.32M |
Full Balance SheetCash Flow
| Operating Cash Flow | 72.50M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 99.89%, with operating and profit margins of 23.58% and 1.72%.
| Gross Margin | 99.89% |
| Operating Margin | 23.58% |
| Pretax Margin | 1.52% |
| Profit Margin | 1.72% |
| EBITDA Margin | 60.44% |
| EBIT Margin | 23.58% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $3.00, which amounts to a dividend yield of 8.72%.
| Dividend Per Share | $3.00 |
| Dividend Yield | 8.72% |
| Dividend Growth (YoY) | -21.43% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.95% |
| Shareholder Yield | 6.79% |
| Earnings Yield | -0.70% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
The average price target for GMRE is $40.50, which is 18.20% higher than the current price. The consensus rating is "Buy".
| Price Target | $40.50 |
| Price Target Difference | 18.20% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 3.86% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 22, 2025. It was a reverse split with a ratio of 1:5.
| Last Split Date | Sep 22, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |
